Genmab A/S Stock

Genmab A/S CROIC

The Cash Return on Invested Capital (CROIC) of Genmab A/S (GMAB.CO) as of Jul 26, 2026 is 10.03 %. In the previous year, Cash Return on Invested Capital (CROIC) was 20.67 % — a change of -51.47% (lower).

CROIC

10.03 %

YoY

-51.47%

Last updated:

Cash Return on Invested Capital (CROIC) of Genmab A/S is 2026 10.03 % . Cash Return on Invested Capital (CROIC) of Genmab A/S was 2025 20.67 % . It decreases by -51.47% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Cash Return on Invested Capital (CROIC) of Genmab A/S is 10.03 % in 2026.

Access this data via the Eulerpool API

Profitability — Genmab A/S

All Key Metrics — Genmab A/S